MGC VENTURE PARTNERS 2018 GP, LLC
MGC VENTURE PARTNERS 2018 GP, LLC is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US investing in healthcare-services, pharmaceuticals, biotechnology, healthcare-devices and healthcare-supplies.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- healthcare-services, pharmaceuticals, biotechnology, healthcare-devices, healthcare-supplies
- Invests in
- US-wide
- Founded
- 2018
- Assets under management
- $125M
Check size not disclosed
Thesis
Its investment targets include healthcare services, pharmaceuticals, biotechnology, and healthcare devices and supplies. While the fund's legal structure suggests a VC mandate, specific details regarding its investment thesis, geographic scope, stage preferences (pre-seed, seed, Series A-C, growth), and precise strategy (e.g., lead vs. follow, instrument types) are not publicly disclosed. The total AUM is undisclosed, but MGC Venture Partners 2018 LP raised $48.6 million in 2018 against a $125.0 million offering. Typical check sizes are also not publicly available. The firm's principal place of business is in Nashville, Tennessee. It is registered as an Exempt Reporting Adviser (ERA) with the SEC. Due to its limited public profile, lack of a dedicated website, and absence from major allocator databases, information on pitch submission processes or contact emails is unavailable. The firm's discretion may indicate a minimal or transactional role in the venture ecosystem.
Common questions
Does MGC VENTURE PARTNERS 2018 GP, LLC invest at the Pre-seed stage?
Yes. MGC VENTURE PARTNERS 2018 GP, LLC lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does MGC VENTURE PARTNERS 2018 GP, LLC invest?
MGC VENTURE PARTNERS 2018 GP, LLC invests in the US.